Holen Sie sich die Stockscreener-App
1.635
0.91%
-0.015
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
Rosalind Advisors Inc. Purchases 1,616,644 Shares of InspireMD, Inc. $NSPR - MarketBeat
Aug PreEarnings: Is InspireMD Inc stock risky to hold now2026 Short Interest & Weekly Top Stock Performers List - baoquankhu1.vn
InspireMD, Inc. Scheduled to Release Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - Quiver Quantitative
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Carotid stent developer InspireMD sets March 18 results call - Stock Titan
Is InspireMD Inc. stock dividend yield sustainableWeekly Risk Report & Verified Momentum Watchlists - Naître et grandir
InspireMD Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
InspireMD Announces Planned Departure of Chief Operating Officer - TipRanks
InspireMD announces dismissal of chief operating officer Andrea Tommasoli By Investing.com - Investing.com South Africa
InspireMD announces dismissal of chief operating officer Andrea Tommasoli - Investing.com
Embolic Protection Devices Market to Reach USD 1,161.31 Million by 2032, Growing at a CAGR of 7.58% | DelveInsight - Barchart.com
InspireMD (NSPR) outlines COO dismissal, French-law notice and €61k severance - Stock Titan
InspireMD, Inc. Announces Dismissal of Chief Operating Officer Andrea Tommasoli, Effective April 1, 2026 - marketscreener.com
Tangible book value per share of InspireMD Inc. – LSX:A3CMP3 - TradingView
NSPR Technical Analysis & ETF Price Forecast - Intellectia AI
Can InspireMD Inc. outperform in the next rallyJuly 2025 Market Mood & AI Powered Buy and Sell Recommendations - mfd.ru
NSPR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Stock Report: Why is InspireMD Inc stock going upEarnings Growth Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
InspireMD (NSPR) Price Target Increased by 25.00% to 5.10 - Nasdaq
Lake Street reiterates InspireMD stock rating citing market growth By Investing.com - Investing.com Canada
Director adds 2,710 InspireMD (NSPR) shares in amended Form 4 - Stock Titan
What hedge fund activity signals for InspireMD Inc. stock2025 Growth vs Value & Detailed Earnings Play Strategies - mfd.ru
Aberdeen Group plc Makes New Investment in InspireMD, Inc. $NSPR - Defense World
Can InspireMD Inc. ride the EV wavePortfolio Growth Summary & Free AI Powered Buy and Sell Recommendations - mfd.ru
Is InspireMD Inc. stock a top momentum playJuly 2025 Highlights & Weekly Breakout Stock Alerts - mfd.ru
How InspireMD Inc. stock performs in interest rate cyclesEarnings Growth Summary & Weekly High Return Stock Opportunities - mfd.ru
OrbiMed discloses sizable passive stake in InspireMD (NSPR) common stock - Stock Titan
NSPR PE Ratio & Valuation, Is NSPR Overvalued - Intellectia AI
What is InspireMD Inc. s debt to equity ratioJuly 2025 Trends & Accurate Intraday Trading Signals - mfd.ru
Is InspireMD Inc. stock a contrarian buyJuly 2025 Decliners & Community Consensus Trade Signals - mfd.ru
Will InspireMD Inc. stock see PE expansionJuly 2025 Setups & Community Verified Swing Trade Signals - mfd.ru
Will InspireMD Inc. stock hit new highs in YEAR2025 Stock Rankings & Daily Profit Focused Stock Screening - mfd.ru
Rosalind funds disclose 9.2% InspireMD (NSPR) stake with warrant blocker - Stock Titan
Aberdeen Group plc Expands Stake in InspireMD Inc with Strategic Acquisition - GuruFocus
Gains Report: Why is InspireMD Inc stock going upMarket Trend Summary & Daily Price Action Insights - baoquankhu1.vn
This Insider Has Just Sold Shares In InspireMD - simplywall.st
InspireMD CCO Gleason sells $99k in NSPR stock By Investing.com - Investing.com South Africa
InspireMD (NYSE:NSPR) Now Covered by Maxim Group - Defense World
InspireMD (NYSE:NSPR) Insider Shane Thomas Gleason Sells 8,411 Shares - MarketBeat
Shane Thomas Gleason Sells 17,593 Shares of InspireMD (NYSE:NSPR) Stock - MarketBeat
Shane Thomas Gleason Sells 12,395 Shares of InspireMD (NYSE:NSPR) Stock - MarketBeat
InspireMD CCO Gleason sells $99k in NSPR stock - Investing.com
Aug Spikes: Why is InspireMD Inc stock going upJuly 2025 Breakouts & High Accuracy Trade Alerts - baoquankhu1.vn
Rate Cut: Is InspireMD Inc part of any ETFJuly 2025 Movers & Precise Entry and Exit Recommendations - baoquankhu1.vn
Jobs Data: Why is InspireMD Inc stock going upBear Alert & Weekly Momentum Stock Picks - baoquankhu1.vn
InspireMD (NYSE:NSPR) versus Motus GI (NASDAQ:MOTS) Critical Contrast - Defense World
InspireMD (NYSE:NSPR) Stock Price Down 1.8%Should You Sell? - MarketBeat
One new InspireMD hire gets 36,118-share inducement grant - Stock Titan
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
InspireMD Approves Inducement Grants of 36,118 Shares to New Employee - Intellectia AI
Performance Recap: Is M tron Industries Inc stock a good dividend stockDividend Hike & Fast Gain Stock Trading Tips - baoquankhu1.vn
Wall Street Recap: Can InspireMD Inc keep up with sector leadersVolume Spike & Consistent Return Strategy Ideas - baoquankhu1.vn
Buyback Watch: Is InspireMD Inc stock risky to hold nowQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
Options Flow: Can InspireMD Inc be recession proofJuly 2025 Intraday Action & Fast Moving Stock Watchlists - baoquankhu1.vn
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC) - The Manila Times
InspireMD's CGuard® Prime Carotid Stent System Achieves Landmark Safety and Efficacy Results in C-GUARDIANS Trial Published in JACC - Quiver Quantitative
New carotid stent study reports low stroke rates for high-risk patients - Stock Titan
0.93%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):